Nanjing Well Pharmaceutical Group Co., Ltd. (603351)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
26. 65
+0.15
+0.566%
¥
3.47B Market Cap
- P/E Ratio
1.2% Div Yield
2.79M Volume
- Eps
¥ 26.5
Previous Close Want to track 603351 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
603351 Earnings Reports FAQ
What is the earnings per share (EPS) for 603351?
EPS data for 603351 is currently not available, as Nanjing Well Pharmaceutical Group Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Nanjing Well Pharmaceutical Group Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Nanjing Well Pharmaceutical Group Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nanjing Well Pharmaceutical Group Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 603351 at this time, as Nanjing Well Pharmaceutical Group Co., Ltd has no recent EPS data to calculate it.
